An herb with the unlikely name of horse chestnut may prove to hold some of the keys to managing chronic venous insufficiency (CVI). Approximately 10%-15% of men and 20%-25% of women are afflicted by ...
Impact of information sources on expectation of cancer treatment side effects: A URCC CCOP study No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2004 ASCO ...
FDA has until May 25, 2026 to object to the notification, after which the Company will be free to market its proposed dietary supplement containing Australian Chestnut Extract Company has signed an ...